Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.54+0.00 (+0.51%)
Close on Nov 13, 2026Market cap $14.69MP/E –Yield –
Citius Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Citius Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2022 was -37378.5%. For fiscal 2022 it was -37378.5%, against -25616.0% the year before. The highest annual figure on record is -16715.5% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | -37378.5% | −11762.5 |
| FY2021 | Sep 30, 2021 | -25616.0% | −6118.2 |
| FY2020 | Sep 30, 2020 | -19497.9% | −2206.6 |
| FY2019 | Sep 30, 2019 | -17291.3% | −575.8 |
| FY2018 | Sep 30, 2018 | -16715.5% | +4054.4 |
| FY2017 | Sep 30, 2017 | -20769.9% | – |
See a number that looks wrong?